iPSC technology, organoids, and regenerative medicine — study the frontier of medical science at top global universities — guided by AbroBot's 0% Commission platform.
Get Free Counselling| University / Institute | Country | Program | Annual Fees |
|---|---|---|---|
| University of Cambridge | UK | MPhil Stem Cell Medicine | £28,000 |
| University of California, San Francisco | USA | MS Developmental & Stem Cell Biology | USD $44,000 |
| Karolinska Institutet | Sweden | MSc Biomedicine (Stem Cells) | SEK 150,000 |
| University of Melbourne | Australia | Master of Biomedical Science (Stem Cells) | AUD $38,000 |
| Heidelberg University | Germany | MSc Molecular Biosciences (Cell Biology) | €500/sem |
Stem cell therapies and organoid technology are moving rapidly from research to clinical application. CAR-T cell therapies have already gained FDA/EMA approval for blood cancers. Induced pluripotent stem cells (iPSCs) are enabling patient-specific drug testing and organ development. Companies like BlueRock Therapeutics (Bayer), Vertex Pharmaceuticals, and Crispr Therapeutics are leading commercial development. Stem cell scientists earn USD $65,000–$110,000; senior researchers at major institutes earn USD $120,000–$180,000.